<DOC>
	<DOCNO>NCT01232946</DOCNO>
	<brief_summary>The investigator test hypothesis effect liraglutide plus insulin detemir myocardial fuel selection great effect either agent alone . 27 Type 2 diabetic subject ( HbA1c 7.5 - 9.5 % ) currently treat diet exercise alone oral antidiabetic agent randomly assign one three treatment group : insulin detemir , liraglutide , liraglutide plus detemir ( 9 subject per group ) . All subject undergo initial standardization background treatment metformin 2000 mg per day , follow randomized assignment 3 month ' treatment liraglutide 1.8 mg/day ( daily morning , taper accord label instruction ) and/or detemir ( administer twice daily , initially 10 unit per day titrate achieve fasting morning glucose reading 130 mg/dL ) . PET measurement myocardial fuel selection take place end treatment period , fast condition morning follow day 's treatment injection ( ) .</brief_summary>
	<brief_title>Cooperation Insulin GLP-1 Myocardial Glucose Uptake</brief_title>
	<detailed_description />
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<mesh_term>Liraglutide</mesh_term>
	<criteria>Type II diabetic 1850 year BMI &gt; 25kg/m2 HbA1c 7.010.0 % Treated 2 oral agent Chronic illness infection ( diabetes mellitus ) Known coronary artery disease , structural heart disease abnormal ECG screen . Treatment &gt; 2 antihypertensive agent blood pressure &gt; 140/95 two occasion screen History claustrophobia , musculoskeletal factor would result inability comfortably remain within PET scanner gantry duration image protocol . Occupational , investigational know radiation exposure together plan radiologic study , result great 500 mrem total exposure 12 month period . Current pregnancy Treatment GLP1 agonist DPP4 inhibitor within past 6 month Known intolerance GLP1 agonist Personal history pancreatitis , personal family history medullary thyroid carcinoma , contraindication liraglutide treatment . Recognized microvascular complication ( neuropathy , nephropathy , retinopathy ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>Myocardial metabolism</keyword>
</DOC>